You are viewing an incomplete version of our website. Please click to reload the website as full version.

WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (C-Term) Peptide

Details for Product No. ABIN1383472, Supplier: Login to see
Protein Name
  • zgc:64205
  • WIPI1
  • atg18
  • wipi49
  • MGC145296
  • ATG18
  • ATG18A
  • WIPI49
  • 4930533H01Rik
  • AW411817
  • D11Ertd498e
  • RGD1307754
Protein Region
C-Term
Origin
Human
2
2
Application
Blocking Peptide (BP)
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (C-Term) antibody (ABIN1077376)
Characteristics 17 amino acids near the carboxy terminus of human WIPI1.
Human
Research Area Cancer, Apoptosis/Necrosis, Autophagy
Application Notes WIPI1 peptide is used for blocking the activity of WIPI1.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Jeffries, Dove, Michell et al.: "PtdIns-specific MPR pathway association of a novel WD40 repeat protein, WIPI49." in: Molecular biology of the cell, Vol. 15, Issue 6, pp. 2652-63, 2004 (PubMed).